tiprankstipranks
BioRestorative Therapies (BRTX)
NASDAQ:BRTX
US Market

BioRestorative Therapies (BRTX) Financial Statements

Compare
184 Followers

BioRestorative Therapies Financial Overview

BioRestorative Therapies's market cap is currently $13.36M. The company's EPS TTM is $-1.2; its P/E ratio is ―; BioRestorative Therapies is scheduled to report earnings on May 20, 2025, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 401.00K$ 145.80K$ 119.80K$ 46.00K$ 77.00K
Gross Profit$ 372.93K$ 145.80K$ -160.87K$ -159.21K$ 77.00K
Operating Income$ -11.56M$ -15.22M$ -18.97M$ -26.31M$ -2.75M
EBITDA$ -11.56M$ -15.06M$ -18.85M$ -26.22M$ -9.48M
Net Income$ -8.98M$ -10.42M$ -18.02M$ -29.94M$ -12.25M
Balance Sheet
Cash & Short-Term Investments$ 10.73M$ 11.07M$ 14.75M$ 21.03M$ 3.06M
Total Assets$ 12.28M$ 12.61M$ 16.43M$ 22.45M$ 4.35M
Total Debt$ 0.00$ 162.32K$ 301.64K$ 670.70K$ 4.79M
Net Debt$ -547.89K$ -722.06K$ -1.37M$ -20.36M$ 1.73M
Total Liabilities$ 3.75M$ 2.61M$ 602.62K$ 856.50K$ 5.68M
Stockholders' Equity$ 8.53M$ 10.00M$ 15.83M$ 21.60M$ -1.33M
Cash Flow
Free Cash Flow$ -8.23M$ -6.60M$ -6.31M$ -3.36M$ -1.96M
Operating Cash Flow$ -8.23M$ -6.43M$ -5.87M$ -3.33M$ -1.96M
Investing Cash Flow$ 514.53K$ 3.25M$ -13.48M$ -30.66K$ 0.00
Financing Cash Flow$ 7.38M$ 2.35M$ 0.00$ 21.32M$ 5.03M
Currency in USD

BioRestorative Therapies Earnings and Revenue History

BioRestorative Therapies Debt to Assets

BioRestorative Therapies Cash Flow

BioRestorative Therapies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis